Temazepam
Temazepam is an orally administered benzodiazepine commonly prescribed as a treatment for insomnia. It acts by enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA) on synaptic transmission through its interaction with the GABA A receptor.


Introduced in the United States in 1981, temazepam has been widely recognized for its effectiveness as a sleep aid, with more than eight million prescriptions filled annually. Despite its affiliation with the benzodiazepine family, it has not been linked with serum aminotransferase or alkaline phosphatase elevations. Additionally, clinically apparent liver injury from temazepam use has yet to be reported, making it an extremely rare occurrence, if it happens at all.
Indications and Dosage[edit]
The primary indication for temazepam is the short-term treatment of insomnia. It is commercially available in capsule form under several generic names, as well as the brand name Restoril. Dosages range from 7.5 to 30 milligrams, with the recommended initial dose for insomnia being 7.5 milligrams taken before bedtime. This dosage may be increased as required, up to a maximum of 30 milligrams.
Mechanism of Action[edit]
Temazepam's sleep-inducing effect arises from its enhancement of GABA-mediated synaptic transmission inhibition, achieved through its binding to the GABA A receptor. GABA is the principal inhibitory neurotransmitter in the central nervous system and plays a critical role in reducing neuronal excitability.
Side Effects[edit]
The most frequently encountered side effects of temazepam are dose-dependent and can include daytime drowsiness, lethargy, ataxia, dysarthria, and dizziness. While tolerance can develop towards these side effects, it can also occur towards the medication's effects on insomnia.
See Also[edit]
Benzodiazipines[edit]
- Alprazolam
- Chlordiazepoxide
- Diazepam (Oral)
- Estazolam
- Flurazepam
- Lorazepam
- Midazolam
- Oxazepam
- Quazepam
- Temazepam
- Triazolam
Anticonvulsants Drugs[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
